---
title: "Nucala (mepolizumab), all indications: Dosing and administration questions"
description: "Dosing and administration questions on Nucala (mepolizumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Dosing, Administration, and Preparation. Questions: What should be done if a Nucala dose is missed? Where is Nucala injected? How long should Nucala sit out before injecting? How do you reconstitute the Nucala vial? 4 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/nucala/dosing-and-administration"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Nucala (mepolizumab), all indications: Dosing and administration questions

Manufacturer: GlaxoSmithKline  
Prescribing information: [Nucala](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF)  
Indication pages: [Severe eosinophilic asthma](https://www.evicenter.com/medical-information/nucala--severe-eosinophilic-asthma)

## Dosing

<a id="nucala-missed-dose"></a>

### What should be done if a Nucala dose is missed?

> “6. If a dose is missed, administer a dose as soon as possible. Thereafter, the patient can resume 
> dosing on the usual day of administration. If the next dose is already due, then administer as 
> planned.”

Source: [NUCALA: Prescribing information, page 5, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF#page=5)

Note: The instruction is step 6 of the label's section on the prefilled autoinjector and prefilled syringes.

## Administration

<a id="nucala-injection-sites"></a>

### Where is Nucala injected?

> “NUCALA is for subcutaneous use only, and should be injected into the upper arm, thigh, or 
> abdomen”

Source: [NUCALA: Prescribing information, page 2, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF#page=2)

> “3. Administer the subcutaneous injection into the thigh or abdomen, avoiding the 5 cm 
> (approximately 2 inches) around the navel. The upper arm can also be used if a caregiver 
> administers the subcutaneous injection.”

Source: [NUCALA: Prescribing information, page 5, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF#page=5)

> “5. Never give injections into areas where the skin is tender, bruised, red, or hard.”

Source: [NUCALA: Prescribing information, page 5, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF#page=5)

Note: The second and third passages are steps for the prefilled autoinjector and prefilled syringes.

<a id="nucala-before-injection"></a>

### How long should Nucala sit out before injecting?

> “1. Remove the prefilled autoinjector or prefilled syringe from the refrigerator and allow it to sit 
> at room temperature for 30 minutes prior to injection. Do not warm NUCALA injection in 
> any other way.”

Source: [NUCALA: Prescribing information, page 5, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF#page=5)

## Preparation

<a id="nucala-reconstitution"></a>

### How do you reconstitute the Nucala vial?

> “1. Reconstitute NUCALA for injection in the vial with 1.2 mL of Sterile Water for Injection, 
> USP, preferably using a 2- or 3-mL syringe and a 21-gauge needle. The reconstituted 
> solution will contain a concentration of 100 mg/mL mepolizumab. Do not mix with other 
> medications. 
> 2. Direct the stream of Sterile Water for Injection vertically onto the center of the lyophilized 
> powder, which may have a cake-like appearance. Gently swirl the vial for 10 seconds with a 
> circular motion at 15-second intervals until the powder is dissolved. 
> Note: Do not shake the reconstituted solution during the procedure as this may lead to 
> product foaming or precipitation. Reconstitution is typically complete within 5 minutes after 
> the Sterile Water for Injection has been added, but it may take additional time. 
> 3. If a mechanical reconstitution device (swirler) is used to reconstitute NUCALA for injection, 
> swirl at 450 rpm for no longer than 10 minutes. Alternatively, swirling at 1,000 rpm for no 
> longer than 5 minutes is acceptable.”

Source: [NUCALA: Prescribing information, page 3, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF#page=3)

> “4. Visually inspect the reconstituted solution for particulate matter and clarity before use. The 
> solution should be clear to opalescent and colorless to pale yellow or pale brown, essentially 
> particle free. Small air bubbles, however, are expected and acceptable. If particulate matter 
> remains in the solution or if the solution appears cloudy or milky, the solution must not be 
> administered. 
> 5. If the reconstituted solution is not used immediately: 
> • store below 30°C (86°F), 
> • do not freeze, and 
> • discard if not used within 8 hours of reconstitution.”

Source: [NUCALA: Prescribing information, page 4, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF#page=4)

Note: The passages are steps 1 to 5 of the label's reconstitution instructions for the lyophilized powder vial.

## Related pages
- [Medical information: Nucala (mepolizumab): All indications](https://www.evicenter.com/medical-information/nucala)
- [Indication](https://www.evicenter.com/medical-information/nucala/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/nucala/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/nucala/safety)
- [Specific populations](https://www.evicenter.com/medical-information/nucala/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/nucala/drug-interactions)
- [Storage and supply](https://www.evicenter.com/medical-information/nucala/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/nucala/access-and-coverage)
